An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease (PATHOS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01146392
First received: June 16, 2010
Last updated: June 17, 2014
Last verified: June 2014
  Purpose

The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.


Condition
Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Describe the development of COPD health care structure in primary care. [ Time Frame: Data will be extracted from the medical records on one occassion, covering a period of one decade. ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Describe the COPD population in primary care with special reference to treatment, co-morbidity and mortality during last decade. [ Time Frame: Data will be extracted from the medical records on one occassion, covering a period of one decade. ] [ Designated as safety issue: No ]

Enrollment: 27394
Study Start Date: June 2010
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Primary care patients with COPD diagnosis

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Eligible subjects are all COPD patients, found in medical records at the participating swedish primary care clinics. Primarily patients with diagnosis code J44 (ICD-10) stated in the medical record will be investigated. Patient data from the period 1 January 1999 - 31 December 2009 will be included in the observation.

Criteria

Inclusion Criteria:

  • COPD diagnosis according to medical records.
  • Use of drugs prescribed for obstructive lung diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01146392

Locations
Sweden
Research Site
Uppsala, Sweden
Sponsors and Collaborators
AstraZeneca
Investigators
Principal Investigator: Docent Gunnar Johansson Uppsala University, Sweden
Study Chair: Kjell Larsson, Prof Karolinska Institutet
Study Director: Georgios Stratelis, MD AstraZeneca Nordics
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01146392     History of Changes
Other Study ID Numbers: NIS-RSE-DUM-2010/1
Study First Received: June 16, 2010
Last Updated: June 17, 2014
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by AstraZeneca:
Epidemiological
COPD health care
treatment in primary care

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 30, 2014